23/06/2026
Today I was reminded of something important in clinical practice:
A medication can be routine… until it isn’t.
Iron replacement in pregnancy is a cornerstone intervention when clinically indicated, especially in iron deficiency anaemia where maternal and fetal outcomes matter. Intravenous iron has helped many patients avoid prolonged symptoms and improve haemoglobin more efficiently.
But even commonly used therapies deserve respect.
I recently reflected on an acute infusion reaction that occurred shortly after administration of IV iron in an obstetric setting. The patient developed rapid symptoms that prompted immediate cessation of the infusion and clinical intervention. Fortunately, the patient stabilized.
The experience reinforced several lessons:
• Never become complacent with “common” medications
• Monitor patients actively during and after infusions
• Recognize early warning signs of infusion reactions
• Document adverse events thoroughly
• Ensure emergency preparedness in all infusion settings
• Balance vigilance with evidence-based use rare reactions should not overshadow the value of treatment
This is not a post against IV iron. It is a reminder that good clinical care is not only choosing the right therapy it is anticipating, recognizing, and responding when things do not go as expected.
To colleagues in Pharmacy, Obstetrics & Gynaecology, Nursing and Clinical Research:
What protocols or practices have you found most effective for improving infusion safety and patient monitoring?